Twenty years on: the impact of fragments on drug discovery
Top Cited Papers
- 15 July 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 15 (9), 605-619
- https://doi.org/10.1038/nrd.2016.109
Abstract
After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream. More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials. FBDD has been widely applied in both academia and industry, as evidenced by the large number of papers from universities, non-profit research institutions, biotechnology companies and pharmaceutical companies. Moreover, FBDD draws on a diverse range of disciplines, from biochemistry and biophysics to computational and medicinal chemistry. As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future. This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them. It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.Keywords
This publication has 107 references indexed in Scilit:
- Small and colorful stones make beautiful mosaics: fragment-based chemogenomicsDrug Discovery Today, 2013
- Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug DesignJournal of Medicinal Chemistry, 2013
- How Are Fragments Optimized? A Retrospective Analysis of 145 Fragment OptimizationsJournal of Medicinal Chemistry, 2013
- Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17Journal of Chemical Information and Modeling, 2012
- Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionNature Chemical Biology, 2012
- Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated ActivationAngewandte Chemie, 2012
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activityProceedings of the National Academy of Sciences of the United States of America, 2012
- Molecular Interaction Studies Using Microscale ThermophoresisASSAY and Drug Development Technologies, 2011
- Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment CrystallographyJournal of Medicinal Chemistry, 2009
- Structure of a β1-adrenergic G-protein-coupled receptorNature, 2008